MEDIMMUNE, LLC
Patent Owner
Stats
- 161 US PATENTS IN FORCE
- 20 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 161 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,811 Total Citation Count
- Mar 26, 1993 Earliest Filing
- 248 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0204,362 CELL CULTURE METHODS AND MEDIA COMPRISING N-ACETYLCYSTEINEJun 17, 15Jul 20, 17[C12P, C12N, C07K]
2017/0183,397 MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOFMay 04, 15Jun 29, 17[A61K, C07K]
2017/0121,771 INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOFOct 11, 16May 04, 17[C12Q, C07K]
2017/0114,151 MULTISPECIFIC AND MULTIVALENT BINDING PROTEINS AND USES THEREOFAug 08, 16Apr 27, 17[C07K]
2016/0363,591 DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNGJan 26, 15Dec 15, 16[A61K, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9913894 Antibodies against and methods for producing vaccines for respiratory syncytial virusJul 13, 15Mar 13, 18[A61K, C12N, G01N, C07K]
9896505 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseOct 08, 14Feb 20, 18[A61K, C07K]
9879067 Stabilized liquid anti-RSV antibody formulationsFeb 11, 16Jan 30, 18[A61K, C12P, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0088,628 Compositions and Methods for Identifying B Cell Malignancies Responsive to B Cell Depleting TherapyAbandonedDec 09, 16Mar 30, 17[C12Q, C07K]
2017/0073,397 MrkA Polypeptides, Antibodies, and Uses ThereofAbandonedAug 23, 16Mar 16, 17[A61K, C07K]
2017/0015,758 Compositions And Methods For Modulating And Redirecting Immune ResponsesAbandonedJan 21, 15Jan 19, 17[C07K]
2016/0222,099 Methods Of Treatment With Angiopoietin-2 AntibodiesAbandonedJan 29, 16Aug 04, 16[C07K]
2016/0051,660 METHODS OF PRODUCING INFLUENZA VACCINE COMPOSITIONSAbandonedMar 04, 15Feb 25, 16[A61K, C12N]
2016/0039,883 PALIVIZUMAB EPITOPE-BASED VIRUS-LIKE PARTICLESAbandonedMar 14, 14Feb 11, 16[A61K, C12N, G01N, C07K]
2016/0039,906 METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRANSPLANT REJECTIONAbandonedApr 06, 15Feb 11, 16[A61K, C07K]
2016/0038,583 INFLUENZA HEMAGGLUTININ VARIANTS AND USES THEREFORAbandonedOct 01, 14Feb 11, 16[A61K, C12N, C07K]
2015/0361,128 METHODS OF USING ION EXCHANGE CHROMATOGRAPHY TO CONTROL LEVELS OF HIGH MANNOSE GLYCOFORMSAbandonedDec 18, 13Dec 17, 15[C07K]
2015/0344,557 Liquid Antibody Formulation With Improved Aggregation PropertiesAbandonedDec 18, 13Dec 03, 15[C07K]
2015/0284,447 METHOD OF ISOLATING SYNAGIS(R) IN THE ABSENCE OF BENZONASEAbandonedNov 05, 13Oct 08, 15[C07K]
2015/0284,450 COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULESAbandonedNov 06, 13Oct 08, 15[A61K, C07K]
2015/0252,431 COMPOSITIONS AND METHODS FOR IDENTIFYING B CELL MALIGNANCIES RESPONSIVE TO B CELL DEPLETING THERAPYAbandonedMar 04, 15Sep 10, 15[C12Q, C07K]
2015/0190,479 DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUESAbandonedSep 05, 14Jul 09, 15[A61K]
2015/0168,375 CANCER STEM CELLS AND METHODS OF USING THE SAMEAbandonedMar 12, 13Jun 18, 15[G01N, A01K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
